Lundbeck
Lundbeck is a global pharmaceutical company specialized in brain diseases.
Launch date
Employees
Market cap
€5.9b
Enterprise valuation
€5.3b (Public information from Sep 2024)
Share price
DKK39.45 LUN.CO
Copenhagen Capital Region of Denmark (HQ)
Corporate Venture Fund: Lundbeckfonden Ventures
No columns specified